Blumenau begins dengue vaccination on Monday; See who has the right

Parents or guardians should look for a health unit with the brochure in hand (Image: PMB, Disclosure)

Blumenau begins dengue vaccination via SUS next Monday (6). The first 5,057 doses are due to arrive in the city this week, and will cover the public aged 10 to 14 years. According to the city council, the municipality has a population of about 20,000 people in this age group. This means that further shipments of the vaccine will be needed to vaccinate everyone.

Continues after ad

Follow NSC Total news on Google News

Initially, the vaccine will be available in public outpatient clinics in Centro, Garcia, Velha, Itopava, Escola Agricola, Badenfurt and Fortaleza. During the week, stations with Active vaccine room They will also be provided with vaccine doses. The guidance is for parents and guardians to look for one of these units and have their children take the booklet to ensure immunization.

The dengue vaccine is given in two doses, with a three-month interval between doses. The goal is to reduce hospital admissions and deaths from the disease. This year alone, 17 people have died in Blumenau from dengue fever, and hospitalization rates have soared, with nearly 10% of intensive care beds in Vallée do Itajai occupied, according to the state government.

Minister of Health Promotion, Jacqueline Muselin, made an appeal:

Continues after ad

– In addition to working on prevention, we can now provide the residents of Blumenau with greater safety regarding the spread of the disease. We ask the target audience to search for health units that have an active vaccination room and search for the vaccine.

Recommendations

Vaccines containing inactivated viruses, such as influenza, can be given 24 hours after dengue vaccination;

Vaccines containing weakened viruses, such as MMR and yellow fever, can be given 30 days after dengue vaccination;

In cases of dengue virus infection, it is recommended to wait 6 months before starting a dengue (attenuated) vaccine regimen.

Continues after ad

contraindications

Dengue vaccine should not be given in the following cases:

Anaphylaxis or hypersensitivity reaction to the active ingredient or to any excipient listed in the “Vaccine composition” section or to a previous dose of this vaccine;

Individuals with congenital or acquired immunodeficiency, including those receiving immunosuppressive therapies such as chemotherapy or high doses of systemic corticosteroids within four weeks prior to vaccination, as with other live attenuated vaccines;